Millennium Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-278,600
| Closed | -$28.3M | – | 5901 |
|
|
2025
Q4 | $28.3M | Buy |
278,600
+173,200
| +164% | +$13.9M | 0.01% | 1234 |
|
|
2025
Q3 | $5.77M | Buy |
+105,400
| New | +$5.27M | ﹤0.01% | 2985 |
|
|
2025
Q2 | – | Sell |
-250,000
| Closed | -$10.8M | – | 5991 |
|
|
2025
Q1 | $10.8M | Buy |
250,000
+151,200
| +153% | +$7.66M | 0.01% | 2107 |
|
|
2024
Q4 | $5.55M | Buy |
98,800
+86,900
| +730% | +$5.41M | ﹤0.01% | 2727 |
|
|
2024
Q3 | $811K | Sell |
11,900
-18,100
| -60% | -$1.02M | ﹤0.01% | 4437 |
|
|
2024
Q2 | $1.27M | Sell |
30,000
-325,000
| -92% | -$17.9M | ﹤0.01% | 3921 |
|
|
2024
Q1 | $24.5M | Buy |
355,000
+200,000
| +129% | +$12.7M | 0.01% | 1386 |
|
|
2023
Q4 | $11.5M | Buy |
155,000
+34,800
| +29% | +$2.28M | 0.01% | 2055 |
|
|
2023
Q3 | $8.2M | Buy |
120,200
+95,200
| +381% | +$8.08M | ﹤0.01% | 2235 |
|
|
2023
Q2 | $2.35M | Buy |
25,000
+9,300
| +59% | +$725K | ﹤0.01% | 3337 |
|
|
2023
Q1 | $1.06M | Buy |
+15,700
| New | +$1.01M | ﹤0.01% | 4034 |
|
|
2022
Q2 | – | Sell |
-5,000
| Closed | -$350K | – | 7111 |
|
|
2022
Q1 | $350K | Sell |
5,000
-45,500
| -90% | -$3.33M | ﹤0.01% | 5416 |
|
|
2021
Q4 | $3.93M | Buy |
+50,500
| New | +$4.46M | ﹤0.01% | 3139 |
|
|
2021
Q3 | – | Sell |
-7,000
| Closed | -$870K | – | 6909 |
|
|
2021
Q2 | $870K | Sell |
7,000
-13,000
| -65% | -$1.55M | ﹤0.01% | 4792 |
|
|
2021
Q1 | $2.64M | Buy |
20,000
+15,000
| +300% | +$2.05M | ﹤0.01% | 3261 |
|
|
2020
Q4 | $662K | Buy |
+5,000
| New | +$605K | ﹤0.01% | 3995 |
|
|
2020
Q1 | – | Sell |
-20,000
| Closed | -$1.85M | – | 4033 |
|
|
2019
Q4 | $1.85M | Buy |
20,000
+5,000
| +33% | +$440K | ﹤0.01% | 2667 |
|
|
2019
Q3 | $1.35M | Buy |
15,000
+10,000
| +200% | +$1.14M | ﹤0.01% | 2683 |
|
|
2019
Q2 | $590K | Sell |
5,000
-5,000
| -50% | -$504K | ﹤0.01% | 3109 |
|
|
2019
Q1 | $866K | Buy |
10,000
+1,500
| +18% | +$128K | ﹤0.01% | 2945 |
|
|
2018
Q4 | $536K | Sell |
8,500
-6,500
| -43% | -$446K | ﹤0.01% | 2924 |
|
|
2018
Q3 | $1.18M | Buy |
+15,000
| New | +$978K | ﹤0.01% | 2776 |
|
|
2018
Q2 | – | Sell |
-80,000
| Closed | -$3.23M | – | 3885 |
|
|
2018
Q1 | $3.23M | Buy |
+80,000
| New | +$3.9M | ﹤0.01% | 2054 |
|
|
2016
Q4 | – | Sell |
-158,000
| Closed | -$2.93M | – | 3442 |
|
|
2016
Q3 | $2.93M | Buy |
+158,000
| New | +$2.78M | ﹤0.01% | 1676 |
|
|
2016
Q1 | – | Sell |
-610,500
| Closed | -$5.63M | – | 3377 |
|
|
2015
Q4 | $5.63M | Buy |
+610,500
| New | +$5.68M | 0.01% | 1279 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Millennium Management's EXAS Position: Q1 2026 in Review
Millennium Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,441,516 shares — an estimated $350M sold.
Millennium Management first reported a position in EXAS in Q2 2013 and held it in 44 quarters. The position peaked at $350M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Millennium Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 3,441,516 Exact Sciences shares in Q1 2026, an estimated $350M.
- Millennium Management first reported a position in Exact Sciences in Q2 2013 and held it in 44 quarters.
- Millennium Management's Exact Sciences position peaked at $350M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.